Figure 4.
Changes in UACR from (A) pre-enrichment to end-enrichment, and (B) pre-enrichment to double-blind treatment in the atrasentan and placebo group. (C) The difference in UACR between atrasentan and placebo during double-blind treatment.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.